The Risk of Coronary Thrombosis With Cyclo-Oxygenase-2 Inhibitors Does Not Vary With Polymorphisms in Two Regions of the Cyclo-Oxygenase-2 Gene

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/j.1365-2125.2011.03957.x